Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Hong‑Yan Tong"'
Autor:
Yi Zhang, Jie-Jing Qian, Yi-Le Zhou, Xin Huang, Jian-Hu Li, Xue-Ying Li, Chen-Ying Li, Huan-Ping Wang, Yin-Jun Lou, Hai-Tao Meng, Wen-Juan Yu, Hong-Yan Tong, Jie Jin, Hong-Hu Zhu
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Adult T-cell acute lymphoblastic leukemia (T-ALL) is a rare hematological malignancy and significantly linked to poor outcomes. Early T-cell precursor (ETP) leukemia is a unique subtype of T-ALL. The aim of this study is to compare the di
Externí odkaz:
https://doaj.org/article/04fa1d45900b4e4a84fe67e26e49d3d1
Autor:
Jing-Han Wang, Qi Guo, Zhi-Xin Ma, Qiu-Ling Ma, Meng-Xia Yu, Xiu-Feng Yin, Sha-Sha Lu, Hong-Qiong Xie, Yue-Hong Jiang, Dan Shen, Li-Ya Ma, Hui Shi, Wen-Juan Yu, Ye-Jiang Lou, Ying Li, Min Yang, Gai-Xiang Xu, Li-Ping Mao, Jian-Hu Li, Huan-Ping Wang, Dong-Mei Wang, Ju-Ying Wei, Hong-Yan Tong, Jian Huang, Jie Jin
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140622 (2015)
The effect of time from diagnosis to treatment (TDT) on overall survival of patients with acute myeloid leukemia (AML) remains obscure. Furthermore, whether chemotherapy delay impacts overall survival (OS) of patients with a special molecular subtype
Externí odkaz:
https://doaj.org/article/c440f2105e534cc4b0cceff4929c394d
Autor:
Li-xia Zhu, Rong-rong Chen, Lu-lu Wang, Jia-nai Sun, De Zhou, Li Li, Jie-jing qian, Yi Zhang, Hong-yan Tong, Wen-juan Yu, Hai-tao Meng, Wen-yuan Mai, Wan-zhuo Xie, Jie Jin, Xiu-jin Ye, Hong-hu Zhu
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(8)
The purpose of this study was to identify the incidence, sites and main pathogens, and risk factors for infectious complications occurring in patients with adult acute myeloid leukemia (AML) during the first course of venetoclax combined with decitab
Autor:
Yi, Zhang, Bi-De, Zhao, Cheng-Cheng, Wang, Yun-Gui, Wang, Hua-Feng, Wang, Jing-Han, Wang, Li-Xia, Liu, Feng, Lou, Shan-Bo, Cao, Xiao-Xia, Hu, Ai-Jie, Huang, Jian-Min, Yang, Hai-Tao, Meng, Wen-Juan, Yu, Hong-Yan, Tong, Jian-Min, Wang, Jie, Jin
Publikováno v:
Am J Cancer Res
FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) is one of the most common somatic mutations in acute myeloid leukemia (AML). However, the molecular structure characteristics and widely accepted prognostic factors for FLT3-ITD are st
Publikováno v:
Experimental & Therapeutic Medicine. Dec2015, Vol. 10 Issue 6, p2295-2298. 4p.
Autor:
Ming-Fang, Shen, Ju-Ying, Wei, Wen-Juan, Yu, Jing-Han, Wang, Hong-Yan, Tong, Hai-Tao, Meng, Wen-Yuan, Mai, Wen-Bin, Qian, Jie, Jin
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 24(6)
To evaluate the therapeutic efficacy of VICP+L-ASP/TKI on adult patients with B-ALL and to explore the influence factors.Forty-one adult B-ALL patients treated with VICP+L-ASP/TKI from August 2008 to June 2014 were following-up. The complete remissio
Publikováno v:
Experimental and therapeutic medicine. 10(6)
Thrombotic thrombocytopenic purpura (TTP) is acquired in the majority of cases. Traditional therapy consists of plasma exchange (PEX), as well as the administration of certain immunosuppressive agents including steroids. A standard dose of rituximab
Autor:
Hong-yan, Tong, Chao, Hu, Meng-xia, Yu, Qiu-ling, Ma, Fei-fei, Chen, Li, Ye, Ju-ying, Wei, Gai-xiang, Xu, Li-ping, Mao, Ying, Li, Jie, Jin
Publikováno v:
Zhonghua yi xue za zhi. 93(40)
To assess the prevalence and clinical characteristics of isocitrate dehydrogenase 1 and 2 (IDH 1 and IDH2) gene mutations in myelodysplastic syndrome (MDS) patients.Pretreatment bone marrow specimens were enriched for mononuclear cells in 108 adult p
Autor:
Pei-pei, Ye, Qi-tian, Mu, Fei-fei, Chen, Wen-yuan, Mai, Hai-tao, Meng, Wen-bin, Qian, Hong-yan, Tong, Jian, Huang, Yin, Tong, Zhi-mei, Chen, Ji-yu, Lou, Yun-gui, Wang, Wan-mao, Ni, Jie, Jin
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 34(10)
To evaluate the efficacy and safety of the HAA regimen (homoharringtonine, cytarabine and aclarubicin) as induction chemotherapy in de novo acute myeloid leukemia (AML).The efficacy and safety of 236 de novo AML patients who received the HAA regimen
Autor:
Yue-feng, Zhang, Zhi-mei, Chen, Ji-yu, Lou, Wan-mao, Ni, Yun-gui, Wang, Hai-tao, Meng, Hong-yan, Tong, Wen-bin, Qian, Jie, Jin
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 32(12)
To study the clinical characteristics, risk factors and therapeutic outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia (Ph(+)aALL).The clinical data of 117 newly diagnosed adults with Ph(+)ALL in our hospital between Janua